The establishment of the primordial follicle pool is crucial for fertility in mammalian females, and the interruption of overall micro-RNA production by Dicer1 conditional knockout in the female reproductive system results in infertility.
INTRODUCTION
The establishment of the primordial follicle pool is crucial for fertility of mammalian females. In mice, the primordial germ cells migrate to the genital ridge around 11 days postcoitus (dpc) and begin to divide rapidly through mitosis and are called oogonia [1] [2] [3] . The mitosis which oogonia undergoes is with incomplete cytokinesis, so clusters of germ cells arranged in syncytia are yielded and named as germ cell cyst or nests [4] . These nests persist until the time of birth, when germ cells undergo a wave of apoptosis and squamous somatic cells (pregranulosa cells) migrate into the nest [3] . Only one-third of the germ cells survive and become encapsulated by pregranulosa cells, forming primordial follicles [3] . Most of the primordial follicles are formed during the first 4-5 days after birth [3, 5] . Perturbations during this critical period of primordial follicle assembly can significantly affect the size of primordial follicle pool and result in serious reproductive diseases, such as ovarian dysgenesis and premature ovarian failure (POF) [6] . However, the mechanism of primordial follicle assembly and how the disturbance results in reproductive disorders are still poorly understood, even if extensive studies have been carried out.
The reported studies have identified numbers of factors and related signaling pathways involved in the process of primordial follicle assembly-such as estrogen and progesterone [7] [8] [9] [10] , jagged-notch signaling [11] [12] [13] , KIT signaling [14] , Bcl-2 [15] , TAF4b [16] , and follistatin [17] , among which activin was originally identified and isolated from gonadal fluids-and have been proven to play important roles in follicle development at various stages, including primordial follicle assembly [18] [19] [20] . In mice, the decline of activin level or the interruption of activin signaling results in multioocyte follicles (MOFs) [21, 22] , whereas the excessive activin bioavailability in female mice causes an excess of primordial follicles on Postnatal Day (PND) 8.5 and undergoes an accelerated demise in adults, similar to human POF [17] . A similar phenomenon was found in mouse ovaries administered with recombinant human activin A (rh-ActA) on PND 0-4. The administration caused an increased pool size that undergoes a rapid demise until the size of the pool is similar to the untreated controls by puberty [5] . Further studies have shown that activin transduces its signal through its receptors and the serine-threonine kinase/ Smad protein pathway, which involves activin binding receptors (ACVR2A and ACVR2B), a signaling receptor (ACVR1B), signaling coactivators (Smads 2, 3, and 4), and an inhibitor (Smad7) [23] [24] [25] . However, the signaling pathway of activin affecting primordial follicle assembly still needs to be further elucidated.
Micro-RNAs are small noncoding RNA molecular (18-25 nucleotides) that direct the posttranscriptional repression of protein-coding genes by base pairing with the 3 0 -untranslated region (UTR) of target mRNAs [26] . It has been shown that general hypomorphic mutant or conditional knockout of Dicer1 in the female mouse reproductive system leads to infertility [27] [28] [29] , implying important roles of micro-RNA in regulating animal reproduction. Most recently, micro-RNA expression profiles in mammalian gonads have been established [30, 31] . The profiles show that miR-125b is among the most commonly abundant micro-RNA populations in the ovary regardless of species [30] . MiR-125b is transcribed from two loci located on chromosomes 9 (mmu-miR-125b-1) and 16 (mmu-miR-125b-2), and the mature 5 0 -strand micro-RNA sequences are exactly the same, but up to now, there are few data about the functions and mechanisms of miR-125b in the ovary, especially during primordial follicle assembly, although there are reports of miR125b expression and its functions in cancer tissues, such as breast [32] , ovary [33] , and hepatocellular [34] cancers and leukemia [35, 36] .
The aims of the present study were to assay the miR-125b expression pattern in the developing mouse ovaries, its roles in the duration of primordial follicle assembly, and related mechanisms.
MATERIALS AND METHODS

Animals and Tissue Collection
Adult Kunming White mice were purchased from the Animal Institute of the Chinese Medical Academy (Beijing, China) and raised in a controlled temperature (228C-248C) and humidity (60%-70%) on a 12:12 light:dark cycle. Vaginal plug detection was considered on Day 0.5 of pregnancy. Ovaries were collected from mice at different developmental stages and stored at À808C for RNA isolation, immediately fixed for in situ hybridization (ISH) and immunohistochemical studies, or prepared for in vitro culture. All animal experiments were approved by the Chinese Association for Laboratory Animal Sciences.
MiR-125b Detection by ISH
Newborn mouse ovaries were collected and fixed in 4% paraformaldehyde. Cryosections (10 lm thick) were prepared, and the ISH assays were performed as previously described [36] . Briefly, the fixed sections were subjected to acetylation for 15 min and protease K treatment for 10 min, then washed by PBS. Prehybridization was carried out at room temperature (RT) for 6-8 h and followed by hybridization at 558C overnight. After washing by 53 SSC for 10 min in an ice bath, the slides were incubated in a blocking solution for 1 h at RT and incubated with AP-conjugated antibody to digoxingenin at 48C overnight. After PBS and alkaline phosphate buffer washes, the slides were incubated in Nitrotetrazolium Blue chloride and 5-Bromo-4-chloro-3-indolylphosphate ptoluidine salt in the dark until ideal staining was reached. The Mus musculus miR-125b-5p miRCURY LNA micro-RNA detection probes and scrambled probes were purchased from Exiqon and labeled with digoxigenin using a digoxigenin oligonucleotide tailing kit (Roche Diagnostics) following the manufacturer's instructions.
Real-Time PCR
The total RNA of the ovary and about 1 3 10 6 cultured cells in 35-mm culture dishes were extracted using the Trizol Reagent (Vigorous Biotechnology Beijing Co., Ltd) as per the manufacturer's instructions. Real-time PCR was processed as described [37, 38] . Reversed transcriptase reaction was promoted by M-MLV reverse transcriptase (Promega) and contained the purified total RNA (1 lg) and 50 nM RT primer (the RT-miR-125b stem-loop primer, CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGTCA CAAGT, and the U6 RT-primer, AACGCTTCACGAATTTGCGT). The 15-ll reactions were incubated in a DNA Thermal Cycler 4800 for 30 min at 168C, 30 min at 428C, and 5 min at 858C and finally stored at 48C. Real-time PCR was performed by using SYBR Green (Takara) on an ABI 7500 real-time PCR machine (Applied Biosystems) according to the manufacturer's protocols. The expression level of mature miRNAs was normalized to the U6 expression level. The PCR conditions were at 958C for 2 min, 40 cycles at 958C for 5 sec, and 608C for 34 sec. For real-time PCR of mRNAs, GAPDH served as an internal control. Sequences of the primers are listed in Table 1 . Every melting curve in the PCR was single peak. The relative quantification of genes was determined using ABI PRISM 7500 equipped software (Applied Biosystems). All experiments were performed in at least triplicate.
Isolation, Culture, and Treatment of Ovarian Somatic Cells
The isolation of ovarian somatic cells (OSCs) was performed as described [39, 40] . In brief, ovaries were collected at 0 days postpartum (dpp) and digested by 0.5 mg/ml collagenase, 20 lg/ml DNase I, and 13 trypsin/EDTA (Sigma). The layer of granulosa cells was detached from the oocytes, enabling isolation of ovarian cells. For RNA extraction, the suspension of ovarian cells was cultured in 35-mm dishes, and for BrdU ELISA assay, cells were cultured in 96-well dishes in DMEM:HAM-F12 supplemented with 15 mM HEPES, 40 lg/ml gentamycin, and 10% fetal bovine serum (FBS) for 6-8 h to allow the attachment of the OSCs. The unattached oocytes, which were large and round in shape, were collected from the supernatant by centrifugation. For BrdU ELISA assay, the OSCs were transfected after being cultured for 48 h. Ovaries were isolated from newborn mouse and electrotransfected with miR-125b inhibitors or mimics as in our previous report [41] . In brief, 10 lM/ ovary of inhibitors or mimics were injected; nc inhibitors and nc mimics were used as negative controls, respectively. After injection, a 20-V, 50-msec rectangular pulse was charged five times at 150-msec intervals by an electroporator (ECM 2001; BTX). After electroporation, five to six ovaries were pooled and placed in a 24-well dish and cultured in DMEM:HAM-F12, which was free of FBS, and incubated at 378C in a humidified atmosphere of 5% CO 2 . The culture medium was changed every 2 days.
The rh-ActA was added to the culture medium 24 h after the electrotransfection, and ovaries were harvested after 3 days of additional culture for RNA isolation or follicle counting. Rh-ActA was purchased from Peprotech (catalog no. AF-120-14E).
Immunohistochemistry
Cultured ovaries with different treatments were collected, fixed in 4% paraformaldehyde for 2 h at RT, and then embedded and continuously sectioned at 5 lm. After dewaxing, rehydration, antigen retrieval in 0.01 M sodium citrate buffer (pH 6.0) by microwaving samples on high power for 4 min and on low power for 12 min, and blocking endogenous peroxidase activity with 3% H 2 O 2 /PBS for 20 min, another blocking was achieved by immersing slides in a solution containing 10% serum for 1 h at RT. The sections were incubated with VASA antibody (diluted 1:100; Santa Cruz Biotechnology Inc.) and anti-BrdU antibody (diluted 1:50; Developmental Studies Hybridoma Bank) overnight at 48C. Subsequently, biotinylated secondary antibody (Zhongshan Goldenbridge Biotechnology Co., Ltd) and avidinbiotin-peroxidase (Zhongshan Goldenbridge Biotechnology) were incubated, followed by exposure to diaminobenzidine (Zhongshan Goldenbridge Biotechnology) for 1 min. Finally, the sections were counterstained with hematoxylin. Nonimmunized rabbit serum or mouse serum replacing primary antibodies were used as controls.
Western Blot
Ovaries were lysed with RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, and 1 mM PMSF). The protein concentration of each sample was measured using the BCA assay reagent (Vigorous Biotechnology) according to the manufacturer's instructions. Equal amounts of proteins (100 lg) were electrophoresed on a 15% SDS-PAGE for ACVR2A, SMAD2, pho-SMAD2, and GAPDH, and the bands were transferred to a polyvinylidene fluoride (PVDF) membrane (BioRad Laboratories). The membranes were then blocked with 5% (w/v) nonfat dry milk in 0.05 M pH 7.4 Tris-buffered saline (TBS) for 2 h at RT and incubated with ACVR2A antibody (1:10 000; Abcam), SMAD2 and pho-SMAD2 antibody (1:1000; Cell Signaling Technologies), and internal control GAPDH antibody (1:8000; Ambion) overnight at 48C. Then the PVDF membrane was washed by TBST (0.1% Tween-20 in TBS) three times for 30 min and incubated with an appropriate secondary antibody in TBST for 2 h at RT. Finally, the membrane was washed by TBST for 30 min and treated with the Pierce ECL 2 Western Blotting Substrate (Thermo Scientific) at RT from 10 sec to 5 min. Nonimmunized bovine serum replacing primary antibodies were used as controls.
Luciferase Reporter Assay
The luciferase reporter assay was carried out as previously reported [38] . Briefly, the 3 0 -UTR mouse Acvr2a mRNA was cloned and introduced between the NotI and XhoI sites to Renilla luciferase 3 0 -UTR of the psiCHECK À2 vector (Promega). The firefly luciferase vector was used for internal reference. Constructs with mutated 3 0 -UTR of Acvr2a mRNA were used as negative controls. Then a mixture containing 200 ng/ml of the dual-luciferase reporter plasmid and 40 nM miR-125b mimics or nc mimics was transfected into 293T cells. The cells transfected with the mutation in 3 0 -UTR of Acvr2a vectors served as controls for normalization. The luciferase activity was measured by a Modulus II microplate multimode reader (Promega) using a Dual-Lucy Assay Kit (Vigorous Biotechnology Beijing). All transfections were repeated independently at least three times.
Histological Evaluation of Follicle Numbers
The serial sections were labeled with an antibody against VASA, a specific marker for germ cells. Follicles were counted in every fifth section, and only oocytes with a visible nucleus were counted to avoid duplicate counts. Germ cells not surrounded by pregranulosa cells were scored as unassembled (remaining in nests). Follicles were scored as primordial follicles if oocytes with a visible nucleus were surrounded by pregranulosa cells or a mixture of squamous and cuboidal somatic cells. Primary and secondary follicles were scored when oocytes were surrounded by a single or double layer of cuboidal granulosa cells, respectively. Primary and secondary follicle counts were added together as developing follicles. Finally, cumulative germ cell and follicles counts were multiplied by five because four-fifths of the ovary was not analyzed [15] . Follicle populations were expressed as a percentage of the total number of germ cells counted.
Proliferation Assay
For the 5-bromo-2 0 -deoxyuridine (BrdU) incorporation assay, BrdU was added to the cultured ovaries 2 h before the ovaries were collected and examined using immunohistochemistry with an anti-BrdU antibody as described above. The number of BrdU-positive cells was counted across two consecutive sections of the center of the ovary with the largest cross section; these were then averaged.
To confirm the BrdU labeling in germ cells, coimmunofluorescence staining using anti-BrdU antibody and anti-VASA antibody was performed. Fluorescently labeled secondary antibody was purchased from Zhongshan Goldenbridge Biotechnology.
For the BrdU ELISA assay, cell proliferation was measured using the Cell Proliferation ELISA BrdU Kit (Roche) according to the manufacturer's instructions. In brief, BrdU labeling solution was added to culture media and reincubated for an additional 6 h. The culture media were removed and serially incubated with FixDenat, anti-BrdU-POD, washing solution, and substrate solution. Finally, we measured the absorbance of the samples in an ELISA plate reader (BioRad) at 370 nm (reference wavelength ;492 nm).
TUNEL Staining
The degree of oocyte apoptosis was measured by TUNEL assay using an In Situ Apoptosis Detection Kit (S7101; Millipore). Ovaries were fixed, embedded in paraffin, and sectioned to a thickness of 5 lm. Slides were then treated following the manufacturer's instructions in the apoptosis detection kit. Cells positively stained by TUNEL had multiple breaks in their DNA and were deemed to be undergoing apoptosis at the time of fixation. The number of stained cells was counted across two consecutive sections of the center of the ovary with the largest cross section; these were then averaged.
Statistical Analysis
The experiment was repeated at least three times, and the values are presented as mean 6 SEM. One-way analysis of variance (ANOVA) was used for statistical comparisons among multiple groups. ANOVA was performed using GraphPad PRISM 4.0 (GraphPad Software, Inc.). For statistical comparisons between two groups, the Student two-tailed t-test was used. A value of P , 0.05 was considered statistically significant.
RESULTS
MiR-125b Expression in the Developing Mouse Ovary
We assayed miR-125b expression during the development of fetal and neonatal mouse ovaries by real-time PCR and ISH. Real-time PCR results showed that miR-125b expressed at a low level on 11.5 dpc, the earliest stage examined, which persisted until 15.5 dpc, after which miR-125b sharply increased and reached the maximum at 18.5 dpc, followed by a stable decrease from 1 to 7 dpp (Fig. 1A) . Details of the validation of real-time PCR are shown in Supplemental Figure  S1 (Supplemental Data are available online at www.biolreprod. org). It was interesting that the miR-125b expression was much higher in the perinatal period, during which primordial follicle assembly occurs. Then we detected the miR-125b expression in the newborn mouse ovary by ISH, and the results showed that miR-125b ISH staining was intensive in OSCs but weak in oocytes (Fig. 1C) . To further confirm this, we isolated oocytes and OSCs from newborn mouse ovaries. Immunofluorescence for the pregranulosa cell marker FOXL2 [42, 43] showed that 80.7% of the OSCs were FOXL2 protein-positive cells, implying that the majority of the cultured OSCs were pregranulosa cells (Supplemental Fig. S2 ). Real-time PCR for miR-125b expression showed that the level of miR-125b in OSCs was nearly four times higher than in oocytes (Fig. 1B) . This expression pattern of miR-125b suggested that miR-125b may play roles in primordial follicle assembly by acting on OSCs.
MiR-125b Negatively Regulates Primordial Follicle Assembly in the Mouse Ovary
In order to identify the functions of miR-125b, miR-125b inhibitors and miR-125b mimics were transfected into the newborn mouse ovary as previously reported [41] . Real-time PCR analysis showed that miR-125b inhibitors dramatically down-regulated the endogenous miR-125b and that the mimics sharply up-regulated miR-125b expression, and these effects lasted for at least 4 days after the transfection (Fig. 2, A and B) .
Then we counted and evaluated the number of follicles after 4 days of in vitro culture. The results showed that the total number of oocytes did not show much difference between treatment groups (Fig. 2, C-E) . However, miR-125b inhibitortransfected ovaries exhibited a significant increased percentage of germ cells in primordial follicles, 70% versus 50% for controls, and a correspondingly significant reduction in the percentage of germ cells remaining in nests, 21% versus 43% for controls (Fig. 2F) , while miR-125b mimic-transfected ovaries exhibited a reduced percentage of germ cells in primordial follicles, 32% versus 50% for control, and an increase of germ cells in nests, 57% versus 42% for controls (Fig. 2G) . The percentage of more advanced, developing follicles was low in our experiments, and there was no significant difference between groups (Fig. 2, F and G) . The specificity of the antibody used was validated in Supplemental Figure S3 . These suggested that miR-125b negatively regulates primordial follicle assembly in neonatal mouse ovaries.
MiR-125b REGULATES PRIMORDIAL FOLLICLE ASSEMBLY
MiR-125b Inhibits the Proliferation of OSCs During Primordial Follicle Assembly
To elucidate the mechanism of miR-125b influencing the primordial follicle assembly, we assayed the effects of miR125b on OSCs proliferation by BrdU staining. The results showed that there were more positive cells per ovary section in the miR-125b inhibitor group than in the nc inhibitor group (439.6 6 21.8 vs. 244.3 6 17.9) but much fewer in the miR125b mimic group than in the nc mimic group (170.1 6 10.3 vs. 268.9 6 16.4) (Fig. 3, A and B) . Further, we transfected miR-125b inhibitors and mimics into the primary cultured newborn mouse OSCs and analyzed the proliferation by BrdU ELISA Kit analysis (Fig. 3C) . The results supported that miR125b inhibits the proliferation of the OSCs.
Acvr2a Is a Direct Target of miR-125b During Primordial Follicle Assembly
In order to find out the potential targets of miR-125b affecting the OSCs proliferation, we used the computational prediction algorithms (TargetScan 5.1), and the putative target genes were then submitted to the KEGG pathway database (http://www.genome.jp/kegg) [44] for pathway enrichment analysis. Among the putative target genes, Acvr2a was an important component of the activin signaling pathway, which has been proven to play important roles in follicle development FIG. 1. MiR-125b expression in the developing mouse ovary. A) Real-time PCR analysis of miR-125b expression in developing mouse ovaries. Data were obtained from at least six ovaries and are presented as mean 6 SEM. The experiments were repeated at least three times. MiR-125b was normalized to miR-U6. Bars with different letters are significantly different (P , 0.05). B) Real-time PCR for miR-125b in isolated oocytes and OSCs from the newborn mouse ovary. The experiments were repeated at least three times. MiR-125b was normalized to miR-U6. Data are presented as mean 6 SEM. Asterisks indicate statistically significant differences between groups (*P , 0.05). C) MiR-125b detection by ISH in 1-dpp mouse ovary. Scramble, ISH with a DIGlabeled scramble probe, used as a negative control; Mmu-miR-125b, ISH with a DIG-labeled mmu-miR-125b detection probe; Enlarge, enlargements of the area in frame above. Bar ¼ 10 lm.
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at various stages, including primordial follicle assembly. The minimum free energy of hybridization between the predicted target gene and miR-125b by RNAhybrid [45] also supported the possibility that miR-125b could bind at the site (Fig. 4B) .
To determine whether miR-125b directly bound to the 3 0 -UTR of Acvr2a mRNA, a dual-luciferase reporter system was used as previously reported [38] . DNA sequences encoding the wild-type or mutant 3 0 -UTR of Acvr2a mRNA were inserted downstream from the Renilla luciferase coding region in the psiCHECK-2 reporter vector (Fig. 4A) . Each reporter construct was separately cotransfected into 293T cells with miR-125b mimics or nc mimics. A significant decline in relative luciferase activities was observed in cells cotransfected with p-Luc-Acvr2a-3 0 UTR construct and miR-125b mimics compared with cells cotransfected with p-Luc-Acvr2a-3 0 -UTR construct and nc mimics, and no change was observed in cells cotransfected with p-Luc-mut-Acvr2a-3 0 -UTR construct and miR-125b mimics compared with p-Luc-mut-Acvr2a-3 0 -UTR
FIG. 2. MiR-125b negatively regulates primordial follicle assembly in the newborn mouse ovary. A, B)
Real-time PCR of miR-125b in ovaries transfected with miR-125b inhibitors, miR-125b mimics, and their respective controls and cultured for 1 day, 2 days, and 4 days, respectively. The experiments were repeated at least three times. Data were obtained from at least six ovaries pooled together and are presented as mean 6 SEM. Bars with different letters are significantly different (P , 0.05). C) Follicles were detected and counted in sections of mouse ovaries 4 days after transfection. Oocytes were marked by VASA immunolocalization (dark brown). Nc-in, nc inhibitors; miR-125b-in, miR-125b inhibitors; nc-mi, nc mimics; miR-125b-mi, miR-125b mimics. Bar ¼ 20 lm. D, E) Total number of oocytes per ovary after different treatments. F, G) Percentage of germ cells in nests, primordial follicles, and developing follicles after different treatments. Data were obtained from at least six ovaries and are presented as mean 6 SEM. Asterisks indicate statistically significant differences between groups (*P , 0.05).
MiR-125b REGULATES PRIMORDIAL FOLLICLE ASSEMBLY construct and nc mimics (Fig. 4C) . Similar results were observed in the luciferase reporter assay in KK1 cells, a mouse ovary-derived granulosa cell line (Fig. 4D) . As the KK1 cell line is rich in miR-125 expression (Supplemental Fig. S4 ), we also conducted a luciferase reporter assay using miR-125b inhibitors to exclude the influence of endogenous miR-125b on the luciferase activity. The assay was performed in the same way as that in 293T cells, except that miR-125b inhibitors and nc inhibitors were transfected instead of miR-125b mimics and nc mimics. The results showed that the luciferase activity of pLuc-Acvr2a-3 0 -UTR construct was much higher in the miR125b inhibitor group than that in nc inhibitor group, and there was no difference between the p-Luc-mut-Acvr2a-3 0 -UTR cotransfected with the miR-125b inhibitor group and the pLuc-mut-Acvr2a-3 0 -UTR cotransfected with nc inhibitor group (Fig. 4E) . The results above proved that miR-125b could directly bind to the 3 0 -UTR of Acvr2a mRNA, demonstrating that Acvr2a is a direct target gene of miR-125b.
To further confirm the relationship between miR-125b and Acvr2a, the ACVR2A protein level in mouse ovaries from 18.5 dpc to 7 dpp was measured by Western blot. The results showed that the level of ACVR2A significantly increased during the primordial follicle assembly in vivo (Fig. 4F) , while the miR-125b expression decreased only in this duration (Fig.  1A) . Then we assayed the effects of miR-125b on ACVR2A expression in cultured ovaries 4 days after being transfected with miR-125b inhibitors or miR-125b mimics and their respective controls. The results showed that the level of ACVR2A protein increased more in miR-125b inhibitortransfected ovaries than in nc inhibitor ones but decreased more in miR-125b mimic-transfected ovaries than in nc mimic ones (Fig. 4G) . However, neither miR-125b inhibitors nor miR-125b mimics had obvious effects on the level of Acvr2a mRNA (Fig. 4H) . These results demonstrated that miR-125b negatively regulated Acvr2a at the posttranscriptional level during primordial follicle assembly.
MiR-125b Negatively Regulates Activin/Smad2 Signaling During Primordial Follicle Assembly
As it was reported that activin functions by binding to ACVR2A or ACVR2B and activating the intracellular Smads via phosphorylation [46] , we assayed the Smad2 phosphorylation levels in ovaries with knocked down or overexpressed miR-125b by transfection. The results showed that the miR125b inhibitor-transfected group significantly increased the Smad2 phosphorylation compared with the nc inhibitortransfected group, while the miR-125b mimic-transfected group significantly attenuated Smad2 phosphorylation compared with the nc mimic-transfected group (Fig. 5A) .
To further confirm that miR-125b regulated the activin/ Smad2 signaling during primordial follicle assembly, newborn mouse ovaries were cultured with 0 (control), 50, 100, and 200 ng/ml rh-ActA, respectively, for 24 h. Real-time PCR analysis showed that miR-125b expression was significantly reduced by the 100-and 200-ng/ml rh-ActA treatments (Fig. 5C ). Then miR-125b was first knocked down and overexpressed, respectively, by transfecting the miR-125b inhibitors and miR-125b mimics, and 100 ng/ml of rh-ActA were added to the culture medium. Detection of the Smad2 phosphorylation levels by Western blot showed that rh-ActA treatment significantly increased the Smad2 phosphorylation level as expected (Fig. 5B) . While this increasing effect was not affected by miR-125b inhibitors, it was significantly attenuated by miR-125b mimics (Fig. 5B) . These results demonstrated that miR-125b negatively regulated the activin/Smad2 signaling.
MiR-125b Negatively Regulates the Promoting Effects of Activin/Smad2 Signaling on Primordial Follicle Assembly
Further, we counted the follicle number in the 100-ng/ml rhActA treatment group and found that rh-ActA significantly increased the total number of oocytes (4628 vs. 3672) (Fig. 6A) 
FIG. 4. Acvr2a is a direct target of miR-125b.
A) The predicted miR-125b binding site in Acvr2a 3 0 -UTR from http://www.miRNA.org [56] and schematic of inserted Acvr2a-3 0 -UTR sequences. B) A schematic representation of the hybridization between miR-125b and Acvr2a 3 0 -UTR and their minimum free energy. Green and red letters indicate miR-125b and Acvr2a 3 0 -UTR, respectively. C) Relative luminescence intensity detected by the Modulus II microplate multimode reader after miR-125b mimics or nc mimics and dual-luciferase vectors cotransfected into 293T cells. D) Relative luminescence intensity detected by the Modulus II microplate multimode reader after miR-125b mimics or nc mimics and dual-luciferase vectors cotransfected into KK1 cells. E) Relative luminescence intensity detected by the Modulus II microplate multimode reader after miR-125b inhibitors or nc inhibitors and dualluciferase vectors cotransfected into KK1 cells. The experiments were repeated at least three times. Asterisks indicate statistically significant differences between groups (*P , 0.05). F) Western blot analysis of ACVR2A in developing mouse ovaries. G) Western blot analysis of ACVR2A in ovaries transfected and cultured for 4 days. Western blot analysis was performed using at least six ovaries for each group and repeated at least three times. H) Real-time PCR analysis of Acvr2a mRNA in ovaries transfected and cultured for 4 days. Data were obtained from at least six ovaries pooled, and experiments were repeated at least three times. Data are presented as mean 6 SEM. Bars with different letters are significantly different (P , 0.05).
MiR-125b REGULATES PRIMORDIAL FOLLICLE ASSEMBLY and the percentage of germ cells in primordial follicles (71% vs. 55%) with a correspondingly significant reduction in the percentage of germ cells remaining in nests (16% vs. 37%) (Fig. 6B) .
To explain the phenomenon that rh-ActA increased the total number of oocytes, we detected the apoptosis and proliferation of oocytes in ovaries treated with 100 ng/ml of rh-ActA in our experiment. TUNEL staining and counting showed that the number of oocytes undergoing apoptosis was similar between the control and the 100-ng/ml rh-ActA treatment groups (Fig.  6, C and D) , but BrdU labeling showed that the number of BrdU-labeling oocytes (namely, oogonia) in 100-ng/ml rhActA treatment group was significantly more than in the control group (Fig. 6, E and F) . These results proved that rhActA increased the total number of oocytes during primordial follicle assembly by promoting oogonia proliferation, consistent with earlier reports [5] .
Then we counted follicles in ovaries transfected with miR125b inhibitors, miR-125b mimics, and their controls, respectively, before 100 ng/ml of rh-ActA were added to the medium. The results showed that neither miR-125b inhibitors nor miR-125b mimics influence the increased effect of rh-ActA on the total number of oocytes (Fig. 7, A and C) , consistent with the specific localization of miR-125b in OSCs and not in oocytes (Fig. 1, B and C) . MiR-125b inhibitors were also found to have no influence on the increased effect of rh-ActA on primordial follicle assembly ( Fig. 7B and Supplemental Fig.  S5A ), but it was observed that when miR-125b was overexpressed by miR-125b mimics, the percentage of germ cells in nests increased significantly (37% vs. 24%) compared with the nc mimic and rh-ActA treatment group (Fig. 7D and Supplemental Fig. S5B ), demonstrating that high expression of miR-125b attenuates the promoting effects of activin signaling on primordial follicle assembly.
DISCUSSION
The present study reports the expression pattern and functions of miR-125b in the duration of primordial follicle assembly, although previous reports have shown that interruption of overall micro-RNA production by Dicer1 conditional knockout in the reproductive system results in infertility in female mice [27, 47] , and miR-125b is one of the most abundant micro-RNA in mammalian ovary [30] .
Our study demonstrated that miR-125b is involved in regulating mouse primordial follicle assembly. Detection of miR-125b in the developing mouse ovary shows that miR-125b is highly expressed in the first few days after birth, when primordial follicle assembly occurs. This is consistent with the micro-RNA expression profiles reported by earlier studies [31, FIG. 5 . MiR-125b negatively regulates activin/Smad2 signaling during primordial follicle assembly. A) Western blot analysis of Smad2 phosphorylation level in ovaries transfected and cultured for 2 days. B) Western blot analysis of Smad2 phosphorylation level in ovaries transfected and cultured with or without rh-ActA added to the medium. Con, vehicle added to the medium; rh-ActA, 100 ng/ml of rh-ActA added to the medium; nc-inþrh-ActA, miR125b-inþrh-ActA, nc-miþrh-ActA, miR-125b-miþrh-ActA, each representing ovaries transfected with nc inhibitors, miR-125b inhibitors, nc mimics, and miR-125b mimics, respectively, before 100 ng/ml of rh-ActA were added to the culture medium. The ovaries were cultured for 2 days before being harvested and analyzed by Western blot. C) Real-time PCR analysis of miR-125b after being treated with different concentration of rh-ActA for 24 h. Five to six ovaries were pooled for both Western blot and real-time PCR. The experiments were repeated at least three times. Data are presented as mean 6 SEM. Bars with different letters are significantly different (P , 0.05).
WANG ET AL. 47 ]. Due to the lack of miR-125b knockout mouse, we applied an in vitro ovary culture system and electroporation transfection strategy that has been successfully performed in many experiments [41, 48, 49] and shown to be efficient in our experiment. Follicle counting results show that miR-125b has no obvious effect on the total number of oocytes but significantly influences the percentage of oocytes in primordial follicles and that remaining in nests. This may result from the FIG. 6. Activin promotes primordial follicle assembly in the mouse ovary. A) Total number of oocytes per ovary treated and cultured for 4 days. Control, vehicle added to the medium; rh-ActA, 100 ng/ml of rh-ActA added to the medium. B) Percentage of germ cells in nests, primordial follicles, and developing follicles in ovaries treated and cultured for 4 days. Control, vehicle added to the medium; rh-ActA, 100 ng/ml of rh-ActA added to the medium. Data were obtained from at least six ovaries and are presented as mean 6 SEM. Asterisks indicate statistically significant differences between groups (*P , 0.05). C) TUNEL assays for apoptosis were performed in control and 100 ng/ml-rh-ActA-treated ovaries after 4 days of culture. Arrows, TUNEL-positive oocytes. Bar ¼ 25 lm. D) The number of TUNEL-positive oocytes in the largest cross section of all treated ovaries. E) Coimmunofluoresence staining using anti-BrdU antibody and anti-VASA antibody in ovaries after 4 days of culture. Green, BrdU-labeling cells; red, anti-VASA antibody positive cells. White arrows, germ cells; blue arrows, somatic cells. Bar ¼ 25 lm. F) The number of BrdU labeling oogonia in the largest cross section of all treated ovaries. Data were obtained from at least six ovaries and are presented as mean 6 SEM. Asterisks indicate statistically significant differences between groups (**P , 0.01).
MiR-125b REGULATES PRIMORDIAL FOLLICLE ASSEMBLY fact that miR-125b is expressed mainly in OSCs rather than germ cells and suggests that miR-125b has no effects on oocyte survival. BrdU analysis shows that miR-125b significantly inhibits the proliferation of OSCs, consistent with previous reports of its inhibitory effects on ovarian [33] , oral [50] , breast [32, 51, 52] , and hepatocellular [34] cancers. The inhibitory function of miR-125b on OSC proliferation and germ cell nest breakdown supports the potential mechanism that enhanced somatic cell proliferation drives increased follicle formation reported by earlier studies [5] . Besides, miR-125b has also been shown to suppress cell migration [53, 54] . Further studies are needed to elucidate whether miR-125b mediates somatic cell migration within germ cell syncytia to facilitate primordial follicle assembly during germ cell nest breakdown.
Further, the present work demonstrates Acvr2a as the direct target of miR-125b during primordial follicle assembly. As the binding receptor for activin, ACVR2A transphosphorylates the type I receptors, which in turn activate the two intracellular RSmad signal transducers, Smad2 and Smad3. The activated RSmads form heterodimeric complexes with Smad4 and translocate into the nucleus, where they regulate the transcription of target genes. It has been shown that the neonatal mouse ovary was activin responsive, as both activin subunits (bA and bB) and receptors (ACVR1B, ACVR2A, and ACVR2B) are located in the germ cell nests from PND 0 to PND 4 and more apparent in granulosa cells than in oocytes by PND 4 [5] . Western blot shows that miR-125b significantly inhibits Acvr2a at the posttranscriptional level and negatively regulates the downstream Smad signaling. This inhibitory function of miR-125b is very important considering that excessive activin activity could result in an excess of primordial follicles that undergo accelerated demise in adults, similar to human POF [5, 17] . To confirm the idea that miR-125b inhibits the excessive activin/Smad2 signaling, thus ensuring the normal size of the primordial follicle pool, we treated the ovary with 100 ng/ml of rh-ActA in the culture system. The results showed that rh-ActA significantly increased the primordial follicle assembly similar to the administration results in earlier reports [5] , and, just as we expected, miR-125b overexpression significantly blocked the promoting effects of rh-ActA, leaving the increased oocyte number caused by rh-ActA in germ cell nests. However, the miR-125b knockdown did not show any influence on the rhActA effects. This may due to the fact that the promoting effects of excessive rh-ActA on primordial follicle assembly had already been remarkable and could not show a significant increase after miR-125b was knocked down. Besides, there was an interesting phenomenon observed in our experiment that shows that low concentration of rh-ActA (0 or 50 ng/ml) had no effect on miR-125b expression, but when the concentration increased, such as to 100 and 200 ng/ml, rh-ActA significantly reduced the expression level of miR-125b. This observation suggested a potential feedback loop between miR-125b and activin signaling. This potential feedback may help to release activin signaling from the inhibitory effects by miR-125b, as FIG. 7 . MiR-125b attenuates the promoting functions of activin on primordial follicle assembly. A, C) Total number of oocytes per ovary differently treated and cultured for 4 days. nc-inþrh-ActA, miR-125b-inþrh-ActA, nc-miþrh-ActA, miR-125b-miþrh-ActA, each representing ovaries transfected with nc inhibitors, miR-125b inhibitors, nc mimics, and miR-125b mimics, respectively, before 100 ng/ml of rh-ActA were added to the culture medium. B, D) Percentage of germ cells in nests, primordial follicles, and developing follicles in ovaries differently treated and cultured for 4 days. Data were obtained from at least six ovaries and are presented as mean 6 SEM (*P , 0.05).
activin plays important roles in follicle development at various stages [18] [19] [20] , and it was significant in regulating the activity of activin signaling to an appropriate level at different developmental stages. Further studies are needed to elucidate this. We include a model depicting the regulation of miR-125b on activin/Smad2 signaling and the potential feedback loop in Fig. 8 .
Besides activin, there are many other factors that signal through ACVR2A, such as nodal, myostatin, and GDF11 [55] . MiR-125b is speculated to mediate these signaling pathways, as it suppresses the expression of ACVR2A in the neonatal mouse ovary. This needs to be elucidated in further studies.
In conclusion, our study shows that with a high expression in the perinatal mouse ovary, miR-125b negatively regulates primordial follicle assembly. It directly targets Acvr2a and negatively regulates activin/Smad2 signaling. This role of miR125b is of great importance for forming a normal size primordial follicle pool in the first few days after birth. The study counts as it extends our understanding of the mechanism of primordial follicle assembly. It added miR-125b to the very short list of micro-RNA functioning in primordial follicle assembly and may be suggestive for future treatment of patients who suffer from related ovary disease, such as MOF and POF. 
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